Loading insider details...
Beta
Latest Form 4 (Jul 17, 2026): Purchase of 4,882 INM shares, $7.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 17, 2026 | InMed Pharmaceuticals Inc. (INM) | Purchase | 4,882 | $7.6K |
| Jul 2, 2026 | InMed Pharmaceuticals Inc. (INM) | Purchase | 545 | $839.30 |
| Jun 11, 2026 | InMed Pharmaceuticals Inc. (INM) | Purchase | 51,056 | $79.6K |
| Mar 28, 2025 | SOLENO THERAPEUTICS INC (SLNO) | Sale | 400,000 | $26.32M |
| Aug 29, 2024 | SOLENO THERAPEUTICS INC (SLNO) | Sale | 500,000 | $24.36M |
| May 1, 2024 | SOLENO THERAPEUTICS INC (SLNO) | Sale | 750,000 | $35.85M |
| Apr 4, 2024 | Terns Pharmaceuticals, Inc. (TERN) | Sale | 136,255 | $952.4K |
| Nov 22, 2023 | Bolt Biotherapeutics, Inc. (BOLT) | Sale | 1,707 | $1.5K |
| Nov 20, 2023 | Bolt Biotherapeutics, Inc. (BOLT) | Sale | 7,531 | $7.2K |
| Oct 4, 2023 | SOLENO THERAPEUTICS INC (SLNO) | In-the-Money Exercise | 5,215,000 | $13.04M |